Putting the patient in the middle: Part Two

With Dr Ronjon Nag and Martin Hunt.

Evidencing long-term value to funders as well as patients and clinicians.

In the last episode we discussed the different types of funding, what investors are looking for, and what developers should understand to attract investment. In this episode, we continued the conversation with Ronjon and Martin on what comes next: how you can build your team and scale up or expand once you’ve seen real patient benefits, and what comes at the end of the journey.

Over the life cycle of a company there will be different requirements and teams may need to reconfigure, adjust and grow. Based on risk, a company’s needs begin to change and develop, but at an early stage, with a lack of data or experience, it will be difficult to make these decisions. Can this challenge be mitigated? Funding is vital throughout a company or product life cycle, not just at the beginning. How can you ensure your new technology is attractive to investors throughout the entire process? Listen to this week’s episode to learn more. 

Convincing investors to put their money where their health is.

With Dr Ronjon Nag and Martin Hunt.

Throughout this series we've learned about the various steps that are involved in developing and validating new innovations for health care and life sciences. Many of these activities can take a significant amount of time bringing with them an equally significant cost. So, how do you fund these activities and sustain a business until you start generating revenue?

To help us answer these questions and discuss more around the topic of funding, we spoke with Dr Ronjon Nag and Martin Hunt. They both have a wide range of experience in different facets of investment including cutting edge applications such as artificial intelligence and regenerative medicine. Listen to our episode to find out how to innovate in this space and understand where specific policies and societal needs exist.

Understanding the importance of intuitive design for effective solutions.

With Bastian Hauck and Dr Tahreema Matin.

On this week’s episode we continued the conversation with Bastian Hauck and Dr Tahreema Matin considering ways to improve the development of healthcare innovations. In the previous episode we looked at the importance of collaborating with users in the early stages of device development. In this episode we discuss the role of innovators to create solutions that can be easily used, the importance of communication to encourage adoption of any technologies and more. Bastian and Tahreema bring two different perspectives to the table with Bastian being a patient advocate and Tahreema being a clinician.

Exploring the value of user-led co-design for engineers and technologists.

With Bastian Hauck and Dr Tahreema Matin.

On this week’s episode of The Evidence Space we look at the importance of designing healthcare innovations that work for the intended user and what steps can be taken to achieve this. There are different approaches when developing new technologies for use by a clinician versus a patient, therefore different designing interventions need to be in place. How can we better understand the needs of users, whether patients or clinicians, and provide the solutions that they really need? To discuss this topic, we spoke with Bastian Hauck and Dr Tahreema Matin who provide different perspectives from both a patient and clinician point of view.

How technical innovations can address the challenges in participant recruitment and retention for clinical trials during COVID-19 and beyond.

With Dr Adam M Hill and Jeff Ventimiglia.

On this week’s episode, we continued the conversation with Adam M Hill and Jeff Ventimiglia on clinical trials, focusing on the role of participants. COVID-19 has made it more challenging to find participants for clinical trials, but technology has created new opportunities. We discussed the benefits of patients taking part in a clinical trial, as well as the challenges around recruitment and how to overcome this.  

Examining the role of clinical trials in building confidence in new devices, diagnostics and drugs.

With Dr Adam M Hill and Jeff Ventimiglia.

On this episode, we tackle the topic of clinical trials. Clinical trials are often used to show the effectiveness of treatments such as drugs or surgical procedures. But how and when are clinical trials necessary to show that new technologies for health and care deliver the results that they claim? We spoke with Dr Adam M Hill and Jeff Ventimiglia to discuss the use of clinical trials, the different approaches needed for the type of trial, and building regulatory confidence.

The second part of our two-part podcast – driving forward the standard of care using cutting-edge technology while maintaining safety and performance standards.

With Eleonora Harwich and Claudia Martinez

In healthcare, there remains a gap between the review of regulations and meeting them in a practical sense. Manufacturers need to fully describe the intended use of their device to allow them to identify the rules that apply, and the compliance that needs to be demonstrated. On this week’s episode, we continued the conversation with Eleonora Harwich and Claudia Martinez on healthcare regulation. We discuss advice, guidance, and challenges on policy and regulation, keeping up with healthcare technologies while meeting healthcare regulations, and more.

Looking at the role of regulation in the development of innovation in healthcare and differentiating between mandatory rules and optional practical guidance. 

Within the UK and globally, there's been a rapid adoption of digital health technologies. As in several other industries such as manufacturing, transport, or the energy sector, healthcare technology is highly regulated. Standards and guidance for regulation are in place but how do patients know that manufacturers are abiding to them? As new digital health technologies are introduced in healthcare, how are new rules being made and by who? On this week’s episode, we spoke with Eleonora Harwich and Claudia Martinez from Think Tank to discuss healthcare regulation and differentiating between rules that are mandatory and those that are guides.  

The second part of our two-part podcast - design safety in healthcare technologies, mitigating design challenges and the potential harm in digital health interventions.

With Dr Matthew Fenech and Stuart Harrison 

We continued the conversation with Dr Matthew Fenech and Stuart Harrison about clinical safety. On this week’s episode, we looked at the meaning of ‘Safety by design’, mitigating design challenges, how manufactures can demonstrate safety in innovations and more.

The importance of clinical safety and how manufacturers can ensure that it is present when their devices or new treatments are in use.

With Dr Matthew Fenech and Stuart Harrison 

Throughout this series, we’ve started to understand that one of the key aims of clinical testing for medical devices or new therapies, is to ensure that not only is it effective, but also that it is safe and doesn’t have any unintended harmful consequences. In this week’s episode, we focused on clinical safety; what does that mean and how can manufacturers ensure that it is present when their devices or new treatments are in use? Our guests on this episode are Dr Matt Fenech and Stuart Harrison.